Thrombospondin expression in myofibers stabilizes muscle membranes

  1. Davy Vanhoutte
  2. Tobias G Schips
  3. Jennifer Q Kwong
  4. Jennifer Davis
  5. Andoria Tjondrokoesoemo
  6. Matthew J Brody
  7. Michelle A Sargent
  8. Onur Kanisicak
  9. Hong Yi
  10. Quan Q Gao
  11. Joseph E Rabinowitz
  12. Talila Volk
  13. Elizabeth M McNally
  14. Jeffery D Molkentin  Is a corresponding author
  1. University of Cincinnati, United States
  2. Emory University, United States
  3. Northwestern University, United States
  4. Temple University School of Medicine, United States
  5. Weizmann Institute of Science, Israel

Abstract

Skeletal muscle is highly sensitive to mutations in genes that participate in membrane stability and cellular attachment, which often leads to muscular dystrophy. Here we show that Thrombospondin-4 (Thbs4) regulates skeletal muscle integrity and its susceptibility to muscular dystrophy through organization of membrane attachment complexes. Loss of the Thbs4 gene causes spontaneous dystrophic changes with aging and accelerates disease in 2 mouse models of muscular dystrophy, while overexpression of mouse Thbs4 is protective and mitigates dystrophic disease. In the myofiber, Thbs4 selectively enhances vesicular trafficking of dystrophin-glycoprotein and integrin attachment complexes to stabilize the sarcolemma. In agreement, muscle-specific overexpression of Drosophila Tsp or mouse Thbs4 rescues a Drosophila model of muscular dystrophy with augmented membrane residence of βPS integrin. This functional conservation emphasizes the fundamental importance of Thbs' as regulators of cellular attachment and membrane stability and identifies Thbs4 as a potential therapeutic target for muscular dystrophy.

Article and author information

Author details

  1. Davy Vanhoutte

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8147-6953
  2. Tobias G Schips

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Jennifer Q Kwong

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jennifer Davis

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Andoria Tjondrokoesoemo

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Matthew J Brody

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Michelle A Sargent

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Onur Kanisicak

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Hong Yi

    Robert P. Apkarian Integrated Electron Microscopy Core, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Quan Q Gao

    Center for Genetic Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Joseph E Rabinowitz

    Temple University School of Medicine, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Talila Volk

    Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  13. Elizabeth M McNally

    Center for Genetic Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Jeffery D Molkentin

    Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, United States
    For correspondence
    jeff.Molkentin@cchmc.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3558-6529

Funding

Howard Hughes Medical Institute (Molkentin)

  • Jeffery D Molkentin

National Institutes of Health (award P01NS072027)

  • Jeffery D Molkentin

National Institutes of Health (award R01HL105924)

  • Jeffery D Molkentin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were approved by the Institutional Animal Care and Use Committee of the Cincinnati Children's Hospital Medical Center (Protocol# IACUC2013-0013). No human subjects or human tissue was directly used in experiments in this study.

Copyright

© 2016, Vanhoutte et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,572
    views
  • 660
    downloads
  • 50
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Davy Vanhoutte
  2. Tobias G Schips
  3. Jennifer Q Kwong
  4. Jennifer Davis
  5. Andoria Tjondrokoesoemo
  6. Matthew J Brody
  7. Michelle A Sargent
  8. Onur Kanisicak
  9. Hong Yi
  10. Quan Q Gao
  11. Joseph E Rabinowitz
  12. Talila Volk
  13. Elizabeth M McNally
  14. Jeffery D Molkentin
(2016)
Thrombospondin expression in myofibers stabilizes muscle membranes
eLife 5:e17589.
https://doi.org/10.7554/eLife.17589

Share this article

https://doi.org/10.7554/eLife.17589

Further reading

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bhumil Patel, Maryke Grobler ... Needhi Bhalla
    Research Article

    Meiotic crossover recombination is essential for both accurate chromosome segregation and the generation of new haplotypes for natural selection to act upon. This requirement is known as crossover assurance and is one example of crossover control. While the conserved role of the ATPase, PCH-2, during meiotic prophase has been enigmatic, a universal phenotype when pch-2 or its orthologs are mutated is a change in the number and distribution of meiotic crossovers. Here, we show that PCH-2 controls the number and distribution of crossovers by antagonizing their formation. This antagonism produces different effects at different stages of meiotic prophase: early in meiotic prophase, PCH-2 prevents double-strand breaks from becoming crossover-eligible intermediates, limiting crossover formation at sites of initial double-strand break formation and homolog interactions. Later in meiotic prophase, PCH-2 winnows the number of crossover-eligible intermediates, contributing to the designation of crossovers and ultimately, crossover assurance. We also demonstrate that PCH-2 accomplishes this regulation through the meiotic HORMAD, HIM-3. Our data strongly support a model in which PCH-2’s conserved role is to remodel meiotic HORMADs throughout meiotic prophase to destabilize crossover-eligible precursors and coordinate meiotic recombination with synapsis, ensuring the progressive implementation of meiotic recombination and explaining its function in the pachytene checkpoint and crossover control.

    1. Cell Biology
    Jingjing Li, Xinyue Wang ... Vincent Archambault
    Research Article

    In animals, mitosis involves the breakdown of the nucleus. The reassembly of a nucleus after mitosis requires the reformation of the nuclear envelope around a single mass of chromosomes. This process requires Ankle2 (also known as LEM4 in humans) which interacts with PP2A and promotes the function of the Barrier-to-Autointegration Factor (BAF). Upon dephosphorylation, BAF dimers cross-bridge chromosomes and bind lamins and transmembrane proteins of the reassembling nuclear envelope. How Ankle2 functions in mitosis is incompletely understood. Using a combination of approaches in Drosophila, along with structural modeling, we provide several lines of evidence that suggest that Ankle2 is a regulatory subunit of PP2A, explaining how it promotes BAF dephosphorylation. In addition, we discovered that Ankle2 interacts with the endoplasmic reticulum protein Vap33, which is required for Ankle2 localization at the reassembling nuclear envelope during telophase. We identified the interaction sites of PP2A and Vap33 on Ankle2. Through genetic rescue experiments, we show that the Ankle2/PP2A interaction is essential for the function of Ankle2 in nuclear reassembly and that the Ankle2/Vap33 interaction also promotes this process. Our study sheds light on the molecular mechanisms of post-mitotic nuclear reassembly and suggests that the endoplasmic reticulum is not merely a source of membranes in the process, but also provides localized enzymatic activity.